Pricing Log in Create free account

Bioventus Inc. (BVS) vs NovoCure Limited (NVCR)

Bioventus Inc. and NovoCure Limited are both Medical Devices companies. NovoCure Limited is the larger, with a market value of $1.7B against $1.2B — 1.4× the size. NovoCure Limited has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 16.4×. NovoCure Limited grew revenue faster over the last twelve months: 11.0% against 3.14%. Bioventus Inc. has the higher net margin (9.36% vs −21.3%) and the higher return on invested capital (7.34% vs −115.6%). Across the 19 metrics below, Bioventus Inc. leads on 14 and NovoCure Limited on 5.

Valuation

Metric BVS NVCR Medical Devices median
P/E 16.42 n/m 23.22
P/S 1.55 2.33 2.34
P/B 3.25 4.83 2.33
Price to free cash flow 9.57 n/m 23.72
EV/EBITDA 10.83 n/m 11.54
EV/Sales 1.93 1.97 2.24
Earnings yield 6.09% (9.24%) (10.09%)
Free cash flow yield 10.45% (1.56%) (8.47%)

Profitability

Metric BVS NVCR Medical Devices median
Gross margin 68.65% 76.13% 56.01%
Operating margin 10.02% (22.08%) (15.03%)
Net margin 9.36% (21.25%) (20.40%)
Free cash flow margin 16.20% (3.64%) (7.24%)
Return on equity 22.75% (43.22%) (15.32%)
Return on assets 7.89% (14.56%) (19.72%)
Return on invested capital 7.34% (115.56%) (10.33%)

Growth

Metric BVS NVCR Medical Devices median
Revenue growth (TTM) 3.14% 10.95% 8.80%
EPS growth (last fiscal year) 163.46% 21.79% 29.03%
Revenue growth, 5-year CAGR 12.08% 5.80% 15.47%
Net income growth, 5-year CAGR 6.73% 0.00% 0.00%

Health

Metric BVS NVCR Medical Devices median
Debt to equity 0.90 0.58 0.07
Current ratio 1.69 2.89 2.50
Net debt to EBITDA 2.40 1.36 0.49

Dividend

Metric BVS NVCR Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric BVS NVCR Medical Devices median
Market cap 1.16b 1.68b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack